- Home
- HKPD vs NERV Comparison
HKPD vs NERV Comparison
Compare HKPD & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- NERV
- Stock Information
- Founded
- HKPD 2016
- NERV 2007
- Country
- HKPD Hong Kong
- NERV United States
- Employees
- HKPD N/A
- NERV N/A
- Industry
- HKPD Other Pharmaceuticals
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- NERV Health Care
- Exchange
- HKPD Nasdaq
- NERV Nasdaq
- Market Cap
- HKPD 11.9M
- NERV 12.4M
- IPO Year
- HKPD 2025
- NERV 2014
- Fundamental
- Price
- HKPD $0.89
- NERV $1.61
- Analyst Decision
- HKPD
- NERV Hold
- Analyst Count
- HKPD 0
- NERV 1
- Target Price
- HKPD N/A
- NERV $5.00
- AVG Volume (30 Days)
- HKPD 242.0K
- NERV 7.2K
- Earning Date
- HKPD 01-01-0001
- NERV 05-20-2025
- Dividend Yield
- HKPD N/A
- NERV N/A
- EPS Growth
- HKPD N/A
- NERV N/A
- EPS
- HKPD 0.21
- NERV 0.19
- Revenue
- HKPD $20,770,344.00
- NERV N/A
- Revenue This Year
- HKPD N/A
- NERV N/A
- Revenue Next Year
- HKPD N/A
- NERV N/A
- P/E Ratio
- HKPD $4.17
- NERV $8.47
- Revenue Growth
- HKPD 32.91
- NERV N/A
- 52 Week Low
- HKPD $0.88
- NERV $1.15
- 52 Week High
- HKPD $3.79
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- NERV 46.58
- Support Level
- HKPD N/A
- NERV $1.58
- Resistance Level
- HKPD N/A
- NERV $1.72
- Average True Range (ATR)
- HKPD 0.00
- NERV 0.07
- MACD
- HKPD 0.00
- NERV -0.01
- Stochastic Oscillator
- HKPD 0.00
- NERV 13.64
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.